Geron (GERN) Financials

Geron’s latest quarter shows a sharp top-line step up, but the company is still not profitable and continues to burn a meaningful amount of cash. In Q1 2026, revenue rose to $51.8 million, up from $48.0 million in Q4 2025 and $39.6 million in Q1 2025. Gross profit was strong at $50.1 million, but operating expenses were still just below gross profit, leaving only $0.2 million in operating income and a net loss of $3.6 million.

The bigger story is cash flow and balance sheet strength. Geron ended Q1 2026 with $68.9 million in cash and equivalents, $243.5 million in short-term investments, and $26.7 million in long-term investments. That gives the company substantial liquidity, even though operating cash flow was negative $62.9 million in the quarter. The cash burn reflects a business that is still scaling and spending heavily on SG&A and R&D.

• Revenue growth continues: Q1 2026 revenue of $51.8 million was higher than both Q4 2025 ($48.0 million) and Q1 2025 ($39.6 million), showing continued commercial momentum.
• Gross profit remained very strong: Gross profit of $50.1 million implies a very high gross margin, which is a positive sign for the underlying product economics.
• Liquidity remains solid: Cash, restricted cash, and investments totaled well over $330 million at quarter-end, giving Geron a sizable funding cushion.
• Minimal capital spending: Purchases of property, plant and equipment were only $252,000 in Q1 2026, suggesting the business is not very capital intensive.
• Investment portfolio helped offset operations: Investing activities generated $51.9 million of net cash in the quarter, largely because investment maturities exceeded purchases.
• Operating income was essentially breakeven: The company posted $158,000 of operating income, which is close to break-even but still not enough to sustain profitability.
• Interest expense remains meaningful: Interest expense was $7.1 million in Q1 2026, still a notable burden on earnings despite rising revenue.
• Shares outstanding remain elevated: Weighted average diluted shares were about 669 million, so any future earnings recovery will be spread across a large share base.
• Operating cash flow was deeply negative: Geron used $62.9 million in cash from operations in Q1 2026, highlighting ongoing cash burn.
• Working capital needs are heavy: Changes in operating assets and liabilities consumed $63.9 million in the quarter, suggesting the business still has significant cash demands as it grows.

Looking at the broader trend over the last several years, Geron has clearly improved revenue but has not yet translated that growth into sustained profits or positive operating cash flow. Revenue moved from almost nothing in 2022 and 2023 to a much more meaningful run rate in 2025 and 2026. At the same time, operating losses have narrowed at times, but quarterly results remain inconsistent and heavily influenced by spending levels and non-operating items.

Balance sheet trends are mixed but manageable. Total assets increased to $534.1 million in Q1 2026 from $482.1 million in Q1 2025 and $424.9 million in Q1 2024, while total liabilities rose to $305.0 million from $294.2 million and $137.2 million over those same periods. Equity has come down from $344.9 million in Q1 2024 to $229.1 million in Q1 2026, reflecting accumulated losses. Even so, the company still has enough liquid resources to support operations in the near term.

For retail investors, the key takeaway is that Geron is progressing as a commercial-stage company, but profitability and cash generation are still the main hurdles. If revenue keeps growing and operating expenses stabilize, the path to breakeven could improve. For now, the stock story remains centered on execution, expense control, and whether rising sales can eventually outpace the company’s sizable spending base.